The antioxidant effect of preischemic dexmedetomidine in a rat model: increased expression of Nrf2/HO-1 via the PKC pathway.

[1]  Mingcang Wang,et al.  Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study. , 2019, Life sciences.

[2]  Shing-Hwa Liu,et al.  Protection of Dexmedetomidine Against Ischemia/Reperfusion‐Induced Apoptotic Insults to Neuronal Cells Occurs Via an Intrinsic Mitochondria‐Dependent Pathway , 2017, Journal of cellular biochemistry.

[3]  Seungmin Lee,et al.  Dexmedetomidine confers neuroprotection against transient global cerebral ischemia/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4/NF-κB pathway , 2017, Neuroscience Letters.

[4]  M. Nazıroğlu,et al.  Different doses of dexmedetomidine reduce plasma cytokine production, brain oxidative injury, PARP and caspase expression levels but increase liver oxidative toxicity in cerebral ischemia-induced rats , 2017, Brain Research Bulletin.

[5]  Xiahong Luo,et al.  Protective effects of dexmedetomidine on brain function of glioma patients undergoing craniotomy resection and its underlying mechanism , 2016, Clinical Neurology and Neurosurgery.

[6]  Z. Xia,et al.  Dexmedetomidine Pretreatment Attenuates Kidney Injury and Oxidative Stress during Orthotopic Autologous Liver Transplantation in Rats , 2015, Oxidative medicine and cellular longevity.

[7]  F. Khodagholi,et al.  Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia , 2015, Metabolic Brain Disease.

[8]  Hailin Zhao,et al.  Dexmedetomidine Attenuates Oxidative Stress Induced Lung Alveolar Epithelial Cell Apoptosis In Vitro , 2015, Oxidative medicine and cellular longevity.

[9]  S. Y. Park,et al.  Sevoflurane post-conditioning increases nuclear factor erythroid 2-related factor and haemoxygenase-1 expression via protein kinase C pathway in a rat model of transient global cerebral ischaemia. , 2015, British journal of anaesthesia.

[10]  A. Wen,et al.  Neuroprotection by Acetyl-11-Keto-β-Boswellic Acid, in Ischemic Brain Injury Involves the Nrf2/HO-1 defense Pathway , 2014, Scientific Reports.

[11]  Y. Tobe,et al.  Dexmedetomidine improves the histological and neurological outcomes 48h after transient spinal ischemia in rats , 2014, Brain Research.

[12]  Jie Han,et al.  (-)-Epigallocatechin gallate protects against cerebral ischemia-induced oxidative stress via Nrf2/ARE signaling. , 2014, Neurochemical research.

[13]  Lei Zhang,et al.  Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury. , 2014, Molecular medicine reports.

[14]  F. Zhang,et al.  Omega-3 Fatty Acids Protect the Brain against Ischemic Injury by Activating Nrf2 and Upregulating Heme Oxygenase 1 , 2014, The Journal of Neuroscience.

[15]  Y. Jeon,et al.  Postischemic Sevoflurane Offers No Additional Neuroprotective Benefit to Preischemic Dexmedetomidine , 2013, Journal of neurosurgical anesthesiology.

[16]  Lina Yu,et al.  Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats , 2013, Brain Research.

[17]  Xianen Fa,et al.  Participation of protein kinase C in the activation of Nrf2 signaling by ischemic preconditioning in the isolated rabbit heart , 2012, Molecular and Cellular Biochemistry.

[18]  S. Niture,et al.  Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis* , 2012, The Journal of Biological Chemistry.

[19]  P. Narasimhan,et al.  Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. , 2011, Antioxidants & redox signaling.

[20]  Jie Liu,et al.  Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. , 2007, Free radical biology & medicine.

[21]  Shyam Biswal,et al.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.

[22]  A. Kong,et al.  Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2 , 2006, Molecular Cancer Therapeutics.

[23]  M. Fujiki,et al.  Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats , 2006, Neuroscience Letters.

[24]  D. Mochly‐Rosen,et al.  The Role of Protein Kinase C in Cerebral Ischemic and Reperfusion Injury , 2005, Stroke.

[25]  K. Nakashima,et al.  PI3K is a key molecule in the Nrf2‐mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells , 2003, FEBS letters.

[26]  H. Huang,et al.  Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Fujimura,et al.  Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. , 1999, Stroke.

[28]  P. Riekkinen,et al.  Neuroprotective Effects of Dexmedetomidine in the Gerbil Hippocampus after Transient Global Ischemia , 1997, Anesthesiology.

[29]  B. Siesjö,et al.  Models for studying long‐term recovery following forebrain ischemia in the rat. 2. A 2‐vessel occlusion model , 1984, Acta neurologica Scandinavica.

[30]  J. Vicencio,et al.  Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism. , 2016, Pharmacological research.

[31]  T. Sobrino,et al.  Neuroprotective effects of dexmedetomidine conditioning strategies: Evidences from an in vitro model of cerebral ischemia. , 2016, Life sciences.